|
Hello fellow investors / traders,
What would you say if I could give you a play tomorrow that is highly liquid, has an excellent risk v reward profile (based on recent support levels), and has a history of some pretty sick short term gains?
Well that's exactly what Therapy Cells, Inc (TCEL) is offering us.
TCEL has a insanely small market cap of only around $600k (source: www.otcmarkets.com). This alone should get your attention.
But there's plenty more reason to like TCEL for a short term trade.
- TCEL is highly liquid, trading volume is 10m+ shares, and over the past 6 weeks has been trading much more than this.
- Based on my observations of TCEL the past several days, it has a very tight spread - which means getting in and out of a trade with relative ease.
- Over the past couple weeks, TCEL appears to have established strong support between $0.0014-0.0015. It closed at $0.0015 today, so if you were to set your stop just below this support, your risk is dramatically reduced.
- TCEL ran from around $0.0022 to $0.0036 (64% gain in 2 days) in late May, and again in early June from around $0.0018 to $0.0037 (105% gain in 3 days). And back in early March, TCEL ran a massive 2,400% - from the price it is trading at now all the way up to $0.05.
While other newsletters and stock pickers have been alerting their audience at $0.0025+, we have patiently waited for what looks like just the right time - and at a much cheaper level.
Tomorrow, you owe it to yourself to check out this potential triple digit winner (over the coming week).
TCEL has developed and patented a method for growing tendon and articular cartilage for transplant into patients. According to this press release issued by the Company, their technology has already been appraised for $30mm dollars.
In the same press release, TCEL's CEO Dr Casey said with FDA approval, the valuation of the technology could be as much as $300mm dollars.
Based on those numbers, TCEL's technology is worth 11 cents a share and could be worth as much as $1.16 a share.
And with it trading at just $0.0015, do you see the potential?
Now I know it is the time of the year when trading is a little slow and volume can be light. But this is often the best time to snap up cheap shares before traders come back and momentum kicks back into gear.
I think I have outlined some compelling reasons to seriously consider TCEL tomorrow, wouldn't you agree?
Please, do yourself a favor. Take a close look at TCEL right now, so you are prepared for the opening bell.
TCEL has developed and patented a method for growing tendon and articular cartilage for transplant into patients.
TCEL's technology has already been appraised for $30mm dollars.
TCEL's CEO Dr Casey said after the FDA approval the valuation of the technology could be as much as $300mm dollars.
What those numbers mean is the technology is worth 11 cents a share and could be worth as much as
$1.16 a share.
With TCEL trading under a penny a share, you can see it is extremely undervalued.
As more investors jump on this, expect the price to head higher.
As you know, we trade stocks that are undergoing investor awareness campaigns and TCEL is kicking off a large program next week after the holiday.
What do you think is going to happen when hundreds of thousands of new investors find out how undervalued TCEL is?
- See more at: http://whisperfromwallstreet.com/we-arent-done-yet-check-out-tcel/#sthash.x0VBvJgy.dpuf
TCEL has developed and patented a method for growing tendon and articular cartilage for transplant into patients.
TCEL's technology has already been appraised for $30mm dollars.
TCEL's CEO Dr Casey said after the FDA approval the valuation of the technology could be as much as $300mm dollars.
What those numbers mean is the technology is worth 11 cents a share and could be worth as much as
$1.16 a share.
With TCEL trading under a penny a share, you can see it is extremely undervalued.
As more investors jump on this, expect the price to head higher.
As you know, we trade stocks that are undergoing investor awareness campaigns and TCEL is kicking off a large program next week after the holiday.
What do you think is going to happen when hundreds of thousands of new investors find out how undervalued TCEL is?
- See more at: http://whisperfromwallstreet.com/we-arent-done-yet-check-out-tcel/#sthash.x0VBvJgy.dpuf ShiznitStocks.com
Disclaimer
Never invest in any stock featured on our
site or emails unless you can afford to lose your entire investment. For full
disclaimer click here.
ShiznitStocks.com employees are not registered as an Investment Adviser in any
jurisdiction whatsoever. The disclaimer is to be read and fully understood
before using our site, or joining our email list. None of the materials or
advertisements herein constitute offers or solicitations to purchase or sell
securities of the companies profiled herein and any decision to invest in any
such company or other financial decisions should not be made based upon the
information provide herein. Instead ShiznitStocks.com strongly urges you
conduct a complete and independent investigation of the respective companies
and consideration of all pertinent risks. ShiznitStocks.com does not offer such
advice or analysis, and ShiznitStocks.com further urges you to consult your own
independent tax, business, financial and investment advisors. Investing in
micro-cap and growth securities is highly speculative and carries and extremely
high degree of risk. It is possible that an investor's investment may be lost
or impaired due to the speculative nature of the companies profiled. Any
statements that express or involve discussions with respect to predictions,
expectations, beliefs, plans, projections, objectives, goals, assumptions or
future events or performance are not statements of historical fact may be
"forward looking statements". Forward looking statements are based on
expectations, estimates, and projections at the time the statements are made
that involve a number of risks and uncertainties which could cause actual
results or events to differ materially from those presently anticipated.
Forward looking statements in this action may be identified through use of
words such as "projects", "foresee", "expects",
"will", "anticipates", "estimates",
"believes", "understands", or that by statements indicating
certain actions "may", "could", or "might" occur.
Understand there is no guarantee past performance will be indicative of future
results. In preparing this publication, ShiznitStocks.com has relied upon
information supplied by its customers, and press releases which it believes to
be reliable; however, such reliability cannot be guaranteed. Investors should
not rely on the information contained in this website. Rather, investors should
use the information contained in this website as a starting point for doing
additional independent research on the featured companies. The advertisements
in this website are believed to be reliable, however, ShiznitStocks.com and its
owners, affiliates, subsidiaries, officers, directors, representatives and
agents have not completed any due diligence or research on the companies advertised
herein and disclaim any liability as to the completeness or accuracy of the
information contained in any advertisement and for any omissions of materials
facts from such advertisement. ShiznitStocks.com is not responsible for any
claims made by the companies advertised herein. ShiznitStocks.com may receive
compensation and its employees and affiliates may own stock that they have
purchased in the open market either prior, during, or after the release of the
companies profile which is an inherent conflict of interest in
ShiznitStocks.com statements and opinions and such statements and opinions
cannot be considered independent. ShiznitStocks.com reserves the right to buy
and sell shares of the profiled company on the open market before, during or
after the release of the company profile. In such an event, ShiznitStocks.com
will not update its disclaimer to reflect any shares bought or sold on the open
market during the profile coverage. ShiznitStocks.com and its management may
benefit from any increase in the share price of the profiled companies and hold
the right to sell the shares bought at any given time including shortly after
the release of the companies profile. ShiznitStocks.com has
been compensated one thousand dollars from a non-affiliated third party, OTP Group, for the
profile of TCEL. ShiznitStocks.com may on occasion accept compensation in
restricted or free-trading shares for it's marketing services of the company
being profiled, and the third party that might have compensated ShiznitStocks.com
may hold free-trading shares of the company being profiled and could very well
be selling shares of the companies stock at the same time the profile is being
disseminated to potential investors; this should be viewed as a definite
conflict of interest and as such, the reader should take this into
consideration. If ShiznitStocks.com ever accepts compensation in the form
of restricted or free trading shares of the company being profiled and decides
to sell these shares into the public market at any time before, during, or
after the release of the companies profile our disclaimer will be updated
accordingly reflecting the current position of those free trading shares
received as compensation for our services. |